Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Turkish Translation, Cross-Cultural Adaptation, Validity, and Reliability of the ABILHAND-Kids Young CP Scale

NCT07894926 is registered in ClinicalTrials.gov with Istanbul University - Cerrahpasa as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07894926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Turkish Translation, Cross-Cultural Adaptation, Validity, and Reliability of the ABILHAND-Kids Young CP Scale
Lead sponsor
Istanbul University - Cerrahpasa
Phase
Observational
Overall status
Recruiting
Start date
October 30, 2026
Completion date
July 31, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 1 arm.

  • Parents of Children with Cerebral Palsy ABILHAND-Kids Young CP Questionnaire

    Parents or primary caregivers of children aged 2 to 7 years diagnosed with cerebral palsy, participating in the Turkish cross-cultural adaptation and validation study of the ABILHAND-Kids Young CP scale.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Turkish Version of the ABILHAND-Kids Young CP Scale Score At baseline (Day 1) and at retest (Day 10)

    Evaluates manual ability and perceived difficulty in daily activities requiring upper limb use in children aged 2 to 7 years with cerebral palsy, based on parent or primary caregiver reports. The scale consists of 17 items, each scored on a 3-point ordinal scale (0 = impossible, 1 = difficult, 2 = easy). The total raw score ranges from 0 to 34 (converted into a linear Rasch measure from 0 to 100). Higher scores indicate better manual ability (a better outcome).

Lead sponsor's other trials

Istanbul University - Cerrahpasa, most recent start first.

Similar trials

Same condition (Cerebral Palsy) and phase, most recent start first.